| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Common Stock | Options Exercise | $0 | +11,904 | +4.4% | $0.000000 | 283,498 | 04 Jun 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -11,904 | -100% | $0.000000* | 0 | 04 Jun 2024 | Common Stock | 11,904 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Effective June 4, 2024, the Board of Directors accelerated the vesting of outstanding and unvested equity totaling 11, 904 shares of common stock. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |